| 000 | 01480 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250514191311.0 | ||
| 264 | 0 | _c20040802 | |
| 008 | 200408s 0 0 eng d | ||
| 022 | _a1545-9616 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStrober, Bruce E | |
| 245 | 0 | 0 |
_aEtanercept for the treatment of psoriasis: combination therapy with other modalities. _h[electronic resource] |
| 260 |
_bJournal of drugs in dermatology : JDD _c |
||
| 300 |
_a270-2 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAcitretin _xadministration & dosage |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadministration & dosage |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aArthritis, Psoriatic _xdrug therapy |
| 650 | 0 | 4 |
_aCyclosporine _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aEtanercept |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xadministration & dosage |
| 650 | 0 | 4 |
_aKeratolytic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPsoriasis _xdrug therapy |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xadministration & dosage |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xadministration & dosage |
| 700 | 1 | _aClarke, Shari | |
| 773 | 0 |
_tJournal of drugs in dermatology : JDD _gvol. 3 _gno. 3 _gp. 270-2 |
|
| 999 |
_c14883746 _d14883746 |
||